Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (511-520 of 662) with videos related to

Pageof 67
Sort By:
Haematologica|February 14, 2018
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosisMathias Schneeweiss, Barbara Peter, Siham Bibi, et al.
Haematologica|August 5, 2018
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsPeter Valent, Guntram Büsche, Igor Theurl, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
Neoplasia (New York, N.Y.)|May 18, 2018
Phenotyping and Target Expression Profiling of CD34<sup>+</sup>/CD38<sup>-</sup> and CD34<sup>+</sup>/CD38<sup>+</sup> Stem- and Progenitor cells in Acute Lymphoblastic LeukemiaKatharina Blatt, Ingeborg Menzl, Gregor Eisenwort, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
International Archives of Allergy and Immunology|November 2, 2011
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalPeter Valent, Cem Akin, Michel Arock, et al.
Immunobiology|June 25, 2013
Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapyTetiana Garmatiuk, Ines Swoboda, Anna Twardosz-Kropfmüller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigensMatthias Mayerhofer, Karoline V Gleixner, Andrea Hoelbl, et al.
American Journal of Cancer Research|March 10, 2023
Antineoplastic efficacy profiles of avapritinib and nintedanib in <i>KIT</i> D816V<sup>+</sup> systemic mastocytosis: a preclinical studyLina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, et al.
Leukemia Research|January 30, 2007
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent, Hans-Peter Horny, John M Bennett, et al.
Pageof 67

Showing results (511-520 of 662) with videos related to

Sort By:
Pageof 67
Haematologica|February 14, 2018
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosisMathias Schneeweiss, Barbara Peter, Siham Bibi, et al.
Haematologica|August 5, 2018
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsPeter Valent, Guntram Büsche, Igor Theurl, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
Neoplasia (New York, N.Y.)|May 18, 2018
Phenotyping and Target Expression Profiling of CD34<sup>+</sup>/CD38<sup>-</sup> and CD34<sup>+</sup>/CD38<sup>+</sup> Stem- and Progenitor cells in Acute Lymphoblastic LeukemiaKatharina Blatt, Ingeborg Menzl, Gregor Eisenwort, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
International Archives of Allergy and Immunology|November 2, 2011
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalPeter Valent, Cem Akin, Michel Arock, et al.
Immunobiology|June 25, 2013
Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapyTetiana Garmatiuk, Ines Swoboda, Anna Twardosz-Kropfmüller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigensMatthias Mayerhofer, Karoline V Gleixner, Andrea Hoelbl, et al.
American Journal of Cancer Research|March 10, 2023
Antineoplastic efficacy profiles of avapritinib and nintedanib in <i>KIT</i> D816V<sup>+</sup> systemic mastocytosis: a preclinical studyLina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, et al.
Leukemia Research|January 30, 2007
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent, Hans-Peter Horny, John M Bennett, et al.
Pageof 67